0 CHECKOUT

PRODUCT FILTERS

REGION

12
2
1
1
1

COUNTRY

1
1
1

CATEGORIES

  • 39
  • 19
  • 12
  • 11
  • 9
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

9
9
13
121

PUBLISHED

1
39
84
121

PRODUCT TYPE

111
9
1

Search for: "Merck KGaA-Therapeutic Competitors Report"

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

Published:  April 2014
Price:  From

Biopharmaceutical Market: By Source, By End Users (Hospitals & Others) - Forecast (2015 - 2020)

Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical...

Published:  August 2015
Price:  From

Severe Psoriasis - Pipeline Review, H2 2015

Severe Psoriasis - Pipeline Review, H2 2015 Summary The report ‘Severe Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides...

Published:  November 2015
Price:  From

IMS Company Profiles:Merck KGaA

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines,...

Published:  October 2013
Price: 

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  February 2015
Price:  From

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

Published:  August 2012
Price:  From

Lung Cancer Clinical Trial Overview

This report provides insight into the current clinical trial activity surrounding lung cancer by examining industry-sponsored activities and quantifying important development milestones and trial metrics: -...

Published:  March 2014
Price:  From

Endometrial Cancer - Pipeline Review, H2 2015

Endometrial Cancer - Pipeline Review, H2 2015 Summary The report ‘Endometrial Cancer - Pipeline Review, H2 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report...

Published:  November 2015
Price:  From

Endometrial Cancer - Pipeline Review, H1 2015

Endometrial Cancer - Pipeline Review, H1 2015 Summary This, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

Published:  May 2015
Price:  From

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015 Summary This, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic...

Published:  January 2015
Price:  From

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2015

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2015 Summary The report ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2015’, provides an overview of...

Published:  November 2015
Price:  From

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015 Summary The report ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015’, provides an overview of the Relapsing Multiple Sclerosis...

Published:  November 2015
Price:  From

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015 Summary This, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  April 2015
Price:  From

Cartilage Degeneration - Pipeline Review, H1 2014

Cartilage Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cartilage Degeneration - Pipeline Review, H1 2014’, provides an overview of the Cartilage Degeneration’s therapeutic...

Published:  May 2014
Price:  From

Indolent Lymphoma - Pipeline Review, H2 2015

Indolent Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Indolent Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

Published:  August 2015
Price:  From

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

Published:  March 2014
Price:  From

Indolent Lymphoma - Pipeline Review, H1 2015

Indolent Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Gastric Cancer - Pipeline Review, H1 2015

Gastric Cancer - Pipeline Review, H1 2015 Summary: This, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Moderate Psoriasis - Pipeline Review, H2 2015

Moderate Psoriasis - Pipeline Review, H2 2015 Summary The report ‘Moderate Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This report...

Published:  November 2015
Price:  From

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015 Summary This ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015’, provides an overview of the Gastroesophageal...

Published:  February 2015
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation